bioaberdeen limited
bioaberdeen limited Company Information
Company Number
SC561432
Website
-Registered Address
11 queens gardens, aberdeen, AB15 4YD
Industry
Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
Telephone
-
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
-0%
bioaberdeen limited Estimated Valuation
Pomanda estimates the enterprise value of BIOABERDEEN LIMITED at £7m based on a Turnover of £2.1m and 3.41x industry multiple (adjusted for size and gross margin).
bioaberdeen limited Estimated Valuation
Pomanda estimates the enterprise value of BIOABERDEEN LIMITED at £0 based on an EBITDA of £-89.5k and a 7.23x industry multiple (adjusted for size and gross margin).
bioaberdeen limited Estimated Valuation
Pomanda estimates the enterprise value of BIOABERDEEN LIMITED at £0 based on Net Assets of £0 and 1.58x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Bioaberdeen Limited Overview
Bioaberdeen Limited is a live company located in aberdeen, AB15 4YD with a Companies House number of SC561432. It operates in the other letting and operating of own or leased real estate sector, SIC Code 68209. Founded in March 2017, it's largest shareholder is unknown. Bioaberdeen Limited is a young, small sized company, Pomanda has estimated its turnover at £2.1m with rapid growth in recent years.
Upgrade for unlimited company reports & a free credit check
Bioaberdeen Limited Health Check
Pomanda's financial health check has awarded Bioaberdeen Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 6 measures and has 3 areas for improvement. Company Health Check FAQs
6 Strong
1 Regular
3 Weak
Size
annual sales of £2.1m, make it larger than the average company (£797.5k)
- Bioaberdeen Limited
£797.5k - Industry AVG
Growth
3 year (CAGR) sales growth of 56%, show it is growing at a faster rate (1.9%)
- Bioaberdeen Limited
1.9% - Industry AVG
Production
with a gross margin of 75.4%, this company has a comparable cost of product (75.4%)
- Bioaberdeen Limited
75.4% - Industry AVG
Profitability
an operating margin of -4.4% make it less profitable than the average company (37%)
- Bioaberdeen Limited
37% - Industry AVG
Employees
with 7 employees, this is above the industry average (4)
7 - Bioaberdeen Limited
4 - Industry AVG
Pay Structure
There is insufficient data available for this Key Performance Indicator!
- - Bioaberdeen Limited
- - Industry AVG
Efficiency
resulting in sales per employee of £294.6k, this is more efficient (£168.3k)
- Bioaberdeen Limited
£168.3k - Industry AVG
Debtor Days
it gets paid by customers after 50 days, this is later than average (31 days)
- Bioaberdeen Limited
31 days - Industry AVG
Creditor Days
its suppliers are paid after 82 days, this is slower than average (37 days)
- Bioaberdeen Limited
37 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Bioaberdeen Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities for 39 weeks, this is more cash available to meet short term requirements (15 weeks)
39 weeks - Bioaberdeen Limited
15 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 100%, this is a higher level of debt than the average (63.2%)
100% - Bioaberdeen Limited
63.2% - Industry AVG
BIOABERDEEN LIMITED financials
Bioaberdeen Limited's latest turnover from March 2023 is estimated at £2.1 million and the company has net assets of 0. According to their latest financial statements, Bioaberdeen Limited has 7 employees and maintains cash reserves of £1.3 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | 0 | 0 | 0 | 0 | ||
| Number Of Employees | 7 | 8 | 7 | |||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 21,329,937 | 13,574,122 | 2,781,075 | 1,079,500 | 369,431 | 12,616 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 21,329,937 | 13,574,122 | 2,781,075 | 1,079,500 | 369,431 | 12,616 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 285,333 | 1,817,452 | 303,036 | 42,106 | 51,840 | 12,616 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 224,594 | 872,767 | 126,800 | 52,601 | 73,410 | 343 |
| Cash | 1,312,541 | 2,968,074 | 171,431 | 124,984 | 46,572 | 4,563 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 1,822,468 | 5,658,293 | 601,267 | 219,691 | 171,822 | 17,522 |
| total assets | 23,152,405 | 19,232,415 | 3,382,342 | 1,299,191 | 541,253 | 30,138 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 114,377 | 4,153,085 | 384,798 | 33,940 | 17,169 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 1,601,771 | 1,505,208 | 216,469 | 185,751 | 154,653 | 17,522 |
| total current liabilities | 1,716,148 | 5,658,293 | 601,267 | 219,691 | 171,822 | 17,522 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 21,436,257 | 13,574,122 | 2,781,075 | 1,079,500 | 369,431 | 12,616 |
| other liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 21,436,257 | 13,574,122 | 2,781,075 | 1,079,500 | 369,431 | 12,616 |
| total liabilities | 23,152,405 | 19,232,415 | 3,382,342 | 1,299,191 | 541,253 | 30,138 |
| net assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total shareholders funds | 0 | 0 | 0 | 0 | 0 | 0 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 1,497 | 726 | 656 | 0 | 0 | 0 |
| Amortisation | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | ||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | -2,180,292 | 2,260,383 | 335,129 | -30,543 | 112,291 | 12,959 |
| Creditors | -4,038,708 | 3,768,287 | 350,858 | 16,771 | 17,169 | 0 |
| Accruals and Deferred Income | 7,958,698 | 12,081,786 | 1,732,293 | 741,167 | 493,946 | 30,138 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | 0 | 0 | 0 | 0 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | -1,655,533 | 2,796,643 | 46,447 | 78,412 | 42,009 | 4,563 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | -1,655,533 | 2,796,643 | 46,447 | 78,412 | 42,009 | 4,563 |
bioaberdeen limited Credit Report and Business Information
Bioaberdeen Limited Competitor Analysis
Perform a competitor analysis for bioaberdeen limited by selecting its closest rivals, whether from the REAL ESTATE ACTIVITIES sector, other small companies, companies in AB15 area or any other competitors across 12 key performance metrics.
bioaberdeen limited Ownership
BIOABERDEEN LIMITED group structure
Bioaberdeen Limited has no subsidiary companies.
Ultimate parent company
BIOABERDEEN LIMITED
SC561432
bioaberdeen limited directors
Bioaberdeen Limited currently has 4 directors. The longest serving directors include Ms Jennifer Craw (Mar 2017) and Dr Deborah O'Neil (Mar 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Ms Jennifer Craw | United Kingdom | 61 years | Mar 2017 | - | Director |
| Dr Deborah O'Neil | United Kingdom | 53 years | Mar 2018 | - | Director |
| Dr Elizabeth-Ann Rattray | Scotland | 58 years | Mar 2018 | - | Director |
| Professor Andrew Porter | Scotland | 63 years | Mar 2018 | - | Director |
P&L
March 2023turnover
2.1m
-83%
operating profit
-91k
0%
gross margin
75.5%
+1.26%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
0
0%
total assets
23.2m
+0.2%
cash
1.3m
-0.56%
net assets
Total assets minus all liabilities
bioaberdeen limited company details
company number
SC561432
Type
Private Ltd By Guarantee w/o Share Cap
industry
68209 - Letting and operating of own or leased real estate (other than Housing Association real estate and conference and exhibition services) n.e.c.
incorporation date
March 2017
age
7
incorporated
UK
ultimate parent company
accounts
Small Company
last accounts submitted
March 2023
previous names
N/A
accountant
ANDERSON ANDERSON & BROWN AUDIT LLP
auditor
-
address
11 queens gardens, aberdeen, AB15 4YD
Bank
-
Legal Advisor
-
bioaberdeen limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to bioaberdeen limited.
bioaberdeen limited Companies House Filings - See Documents
| date | description | view/download |
|---|
